Ressources

This report outlines the current state of harm reduction funding in low-, mid-, and high- income countries.

Over 180,000 people use crack cocaine in England, yet provision of smoking equipment to support safer crack use is prohibited under UK law.

The objective of this study was to characterize access and barriers to harm reduction and treatment in a racially and ethnically diverse population of people who use drugs (PWUD) and whether access

The objective of this study was to characterize access and barriers to harm reduction and treatment in a racially and ethnically diverse population of people who use drugs (PWUD) and whether access

Disturbances in emotion regulation among people who use opioids receiving methadone maintenance treatment (MMT) was reported in a few small studies.

This intrinsic case study offers a unique perspective on the operation of Drug User Liberation Frontʼs Compassion Club and Fulfillment Centre, delving into its inception, development, implementatio

Much existing research is characterized by a primary focus on the “online” aspects of drug sales facilitated by social media, resulting in a divide between “on”- and “offline” drug dealing.

Gendered differences were explored in how people relate to stimulant use, their motivations for using, and how that manifests in the ways that they engage with and use methamphetamine. 

Illegal drug toxicity (i.e., overdose) is the leading cause of death in British Columbia (BC) for people aged 10–59. Stimulants are increasingly detected among drug toxicity deaths.

It has been suggested that opioid agonist therapy (OAT) may have a secondary benefit of reducing methamphetamine/amphetamine use.

To provide guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as se

In the United States, methamphetamine use is increasing and the context of its use has changed, with reports of illicitly manufactured fentanyl being mixed with metha

They examined the use of cannabis as a substitute for other drug use/addiction (ex.

This review aimed to comprehensively present the geographical variation in drug consumption patterns among the drug using population.

We aimed to address the gap in literature pertaining to MDMA-related harm reduction behaviour and harm experiences within the country.

This study seeks to understand the experiences of people who completed a clinical trial of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.

This study aims to identify the prevalence of methamphetamine use from January 2012 to January 2022, coingestions, hospital course, and readmission rate of admitted patients.

To investigate the individual characteristics, causes and circumstances around deaths in stimulant use, and to examine how individuals who died with stimulants in their body differ from individuals

This study explores treatment experiences of people who use illicit stimulants (PWUS) to identify gaps and perceptions of prospective pharmaceutical stimulant substitution treatments (SST).

This report presents a novel treatment protocol comprised of behavior-targeted and pharmacological components that aims to reduce the intensity and duration of methamphetamine intoxication and with